A-shares movement丨Some influenza Concept stocks rise against the trend, Shandong Lukang Pharmaceutical is approaching its limit up during the session.

Gelonghui, December 23｜Last Friday, Shandong Lukang Pharmaceutical surged during the trading session, approaching a limit up, while Pulike Biological Engineering, Inc., Guangdong Zhongsheng Pharmaceutical, Zhejiang Medicine, and Beijing Tiantan Biological Products Corporation all saw increases. In news, the Peking Center for Disease Control recently announced that the city has entered a high flu season. The disease control department reminds citizens that if they experience fever, cough, or other flu-like symptoms, they should try to avoid crowded places and not go to work or school while sick. Additionally, it has been reported that Japan has entered a flu outbreak period, with about 2,800 schools and kindergartens facing class suspensions. (Gelonghui)

Gelonghui FinanceDec 23 10:40

Pulike Biological Engineering, Inc. (603566.SH): is advancing the research and development of the African swine fever subunit vaccine.

Gelonghui, on December 11, reported that Pulike Biological Engineering, Inc. (603566.SH) stated on the investor interaction platform that the company is advancing the research and development of an African swine fever subunit vaccine.

Gelonghui FinanceDec 11 17:19

Pulike Biological Engineering Gets China Approval for Five-Valent Avian Respiratory Vaccine

MT NewswiresDec 5 18:26

Express News | Pulike Biological Engineering,Inc.: "Minitan Soft Ointment" obtained a new veterinary drug registration certificate.

BreakingsNov 27 15:36

Pulike biological engineering,inc. (603566.SH): Actively promoting the layout of companion animal-related products.

Gelonghui November 26th | Pulike Biological Engineering,Inc. (603566.SH) stated on the investor interaction platform that the company's main business products already cover the prevention and treatment of animal diseases such as livestock, poultry, and pets; the company has long adhered to a "full category" global strategy, fully utilizing independent research and development and technical cooperation to improve the layout of pig and poultry products, and actively promote the layout of companion animal-related products.

Gelonghui FinanceNov 26 16:02

Pulike Biological Engineering,Inc.(603566.SH): There is currently no plan to acquire One Health.

Gelonghui November 26 | Pulike Biological Engineering,Inc. (603566.SH) stated on the investor interaction platform that Yichong Health and Pulike Biological Engineering,Inc. are controlled by the same controlling shareholder, affiliated companies of the company, but the company does not hold shares of Yichong Health. Yichong Health is committed to building a first-class chain of pet hospitals, improving the standardization level and service quality of the pet diagnosis and treatment industry. The company currently has no plans to acquire Yichong Health.

Gelonghui FinanceNov 26 15:59